¿Qué trae la nueva clasificación de las neumonías intersticiales idiopáticas?

Jorge Pulido Arenas, MD.

Texto completo:

PDF

Referencias


American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Resp Crit Care Med. 2002;165:277-304.

Hobbs S, Lynch D. The idiopathic interstitial pneumonias: an update and review. Radiol Clin N Am. 2014;52:105-20.

Travis WD, Costabel U, Hansell DM, King TE Jr, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Resp Crit Care Med. 2013;188:733-48.

Flaherty KR, Andrei AC, King TE Jr, et al. Idiopatic interstitial pneumonia: do community and academic physicians agree on diagnosis? Am J Respir Crit Care Med. 2007;175:1054-60.

Flaherty KR, King TE Jr, Raghu G, et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med. 2004;170;904-10.

Selman M. Hypersensitivity pneumonitis: a multifaceted deceiving disorder. Clin Chest Med. 2004;25:531-47.

Hanak V, Golbin JM, Ryu JH. Causes and presenting features in 85 consecutive patients with hypersensitivity pneumonitis. Mayo Clin Proc. 2007;82:812-16.

van Moorsel CH, van Oosterhout MF, Barlo NP, de Jong PA, van der Vis JJ, Ruven HJ, et al. Surfactant protein C mutations are the basis of a significant portion of adult familial pulmonary fibrosis in a Dutch cohort. Am J Respir Crit Care Med. 2010;182:1419-25.

Lawson WE, Loyd JE, Degryse AL. Genetics in pulmonary fibrosisfamilial cases provide clues to the pathogenesis of idiopathic pulmonary fibrosis. Am J Med Sci. 2011;134:439-3.

Travis WD, Hunninghake G, King TE Jr, Lynch DA, Colby TV, Galvin JR, et al. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society Project. Am J Respir Crit Care Med. 2008;177:1338-47.

Akira M, Inoue Y, Arai T, Okuma T, KAwata Y. Long-term follow-up high-resolution CT findings in non-specific interstitial pneumonia. Thorax. 2011;66:61-5.

Park IN, Jegal Y, Kim DS, Do KH, Yoo B, Shim TS, et al. Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia. Eur Respir J. 2009;33:68-76.

Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, et al. ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JPS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788-824.

Sumikawa H, Johkoh T, Colby TV, Ichikado K, Suga M, Taniguchi H, et al. Computed tomography findings in pathological usual interstitial pneumonia: relationship to survival. Am J Respir Crit Care Med. 2008;177:433-9.

Lynch DA, Godwin JD, Safrin S, Starko KM, Hormel P, Brown KK, et al. Idiopathic Pulmonary Fibrosis Study Group. High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am J Respir Crit Care Med. 2005;172:488-93.

Fraig M, Shreesha U, Savici D, et al. Respiratory bronchiolitis: a clinicopathologic study in current smokers, ex-smokers, and never-smokers. Am J Surg Pathol. 2002;26:647-53.

Vasallo R, Ryu JH. Tobacco smoke-related diffuse lung diseases. Semin Respir Crit Care. 2008;29:643-50.

Portnoy J, Veraldi KL, Schwartz MI, Cool CD, Currant-Everett D, Cherniack RM, et al. Respiratory bronchiolitis-interstitial lung disease: longterm outcome. Chest. 2007;131:664-71.

Doan ML, Guillerman RP, Dishop MK, Nogee LM, Langston C, Mallory GB, et al. Clinical, radiological and pathological features of ABCA3 mutations in children. Thorax. 2008;63:366-73.

Collard HR, Moore BB, Flaherty KR, Brown KK, Kaner RJ, King TE Jr, , et al. Idiopathic Pulmonary Fibrosis Clinical Research Network Investigators. Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care. Med 2007;176:636-43.

Ryerson CJ, Urbania TH, Richeldi L, et al. Prevalence and prognosis of unclassifiable interstitial lung disease. Eur Respir J. 2013;42:750-7.

Barlo NP, van Moorsel CHM, Ruven HJT, Zanen P, van der Bosch JMM, Grutters JC. Surfactant protein-D predicts survival in patients with idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis. 2009;26:155-161.

Kinder BW, Brown KK, McCormack FX, Ix JH, Kervitsky JA, Schwartz MI, et al. Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis. Chest. 2009;135:1557-63.

Satoh H, Kurishima K, Ishikawa H, Ohtsuka M. increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases. J Intern Med. 2006;260:429-34.

Prasse A, Probst C, Bargagli E, Zissel G, Toews GB, Flaherty KR, et al. Serum CC-chemokine ligand 18 concentrations predicts outcome in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2009;179:717-23.




DOI: http://dx.doi.org/10.30789/rcneumologia.v25.n2.2013.114

Métricas de artículo

Vistas de resumen
37




Cargando métricas ...

Enlaces refback

  • No hay ningún enlace refback.


Asociación Colombiana de Neumología y Cirugía de Tórax.
Dirección: Carrera 7 Bis # 123-52 Of. 202, Teléfono: 57(1)3222335 - Bogotá - Colombia.
Sistema OJS - Metabiblioteca |